Am J Otolaryngol Head Neck Surg | Volume 4, Issue 10 | Research Article | Open Access
Anju Radhakrishnan, Gerald Parisutham Sebastian* and Ganeshkumar Balasubramaniam
Department of Otolaryngology, Thanjavur Medical College, India
*Correspondance to: Gerald Parisutham Sebastian
Fulltext PDFBackground and Aim: There is a rapid increase in the incidence of mucormycosis cases during the second wave of COVID-19. The aim of our study is to evaluate the risk factors, pathogenesis, management and challenges faced during the management in otolaryngologist's perspectives.
Methods: We conducted a cross sectional study on 50 post-COVID histopathologically proven mucormycosis patients from May 2021 to July 2021 in a tertiary care hospital Otolaryngological Department of Thanjavur Medical College. We collected details about COVID-19, symptoms, treatment taken, co morbidities, CT and DNE findings and management and analyzed with SPSS
software.
Results: Overall 50 patients 66% are males belongs to middle aged to elderly population. Preexisting diabetes was present in 72% patients and new onset in 28% with a statistically significant relation to the development of diabetic ketoacidosis [p value <0.05]. In our study we had a good recovery in 72% of the patients.
Conclusion: Mucormycosis is a fatal disease with significant morbidity and mortality. Management of this condition in post COVID patients is challenging due to various factors. Early diagnosis, prompt surgical and medical management with proper management of co morbidities will help to overcome these challenges and provides a satisfactory outcome.
Mucormycosis; COVID-19; Diabetes mellitus; Surgical debridement
Radhakrishnan A, Sebastian GP, Balasubramaniam G. Mucormycosis a Conundrum in COVID-19 Second Squall; Otolaryngologist Gauntlet a Juggernaut in Triage and Tutelage. Am J Otolaryngol Head Neck Surg. 2021;4(10): 1164..